The new rules governing access to Canada to psychoactive hemp
Experience ensure the rule of law and improvement of the existing mechanisms to provide patients the possibility of the use of psychoactive cannabis for medical purposes is extremely interesting Ukrainian growers in consideration of changes in the profile law of Ukraine, which will give opportunity to develop the medical use of cannabis in the direction of our country.
August 11 Health Canada announced the entry into force on 24 August the new provisions on access to cannabis used for medical purposes. This document was prepared as a result of the verdict by the Supreme Court of Canada, recognizes the legitimacy of psychoactive cannabis cultivation for medical purposes for personal use. The new Regulation should provide reasonable access to psychoactive cannabis used as a therapeutic agent for the citizens who have received official permission for this.
What changes are made to the new Regulations?
The most revolutionary novels of the new provisions is to describe the mechanisms to ensure Canadians have received official approval from the relevant government agencies, the use of psychoactive cannabis as a therapeutic agent. In particular, the above citizens are allowed to grow their own strictly limited number of plants for their own use or to appoint a person who will be able to officially grow for them a certain amount of cannabis.
According to representatives of Health Canada, the addition of the above stories in a new version of the Regulations will provide access to medical cannabis and solve the problem of reasonable access of patients, issued the relevant decision of the Supreme Court.
What do the new postulates of the Regulations for health professionals?
The new provision does not change the role of the Canadian health care professionals in the management of the process in Canada access to psychoactive hemp for its therapeutic use. They will continue to be responsible for granting permission to use cannabis for medical purposes. The official electronic resource from Health Canada updated guidelines to assist health care professionals in determining the country's proper daily amount or dose of hemp medications for patients who need cannabis therapy. Many municipal and regional authorities of Canada, governing the activities of public health authorities in the territory, as well as the College of Family Physicians of Canada have published guidelines for the directives in the field of health professionals in applying its therapeutic practices psychoactive hemp.
What does this mean for patients?
Persons who have received official authorization from the medical specialist on the use of psychoactive cannabis as a medicine, will still be able to purchase their cannabis intended course, one of the 34 authorized by Health Canada representatives. Patients may also cultivate a limited amount of cannabis for their own use or to appoint someone who can grow them for a strictly limited number of plants.
Persons who have an official document issued by their attending physician may be registered by Health Canada in order to cultivate a fixed number of psychoactive cannabis for therapeutic purposes or to appoint someone who will be able to grow medical marijuana for them. The amount is determined based on the individual daily dose approved by their healthcare providers.
What this means for authorized manufacturers?
34 authorized Canadian producer is currently providing services for the supply of psychoactive hemp for nearly 70 thousand citizens of the country and will continue to be the main source of therapeutic cannabis used for medical purposes, precisely because they provided the raw material is under strict state control. These authorized manufacturers will not only continue to provide patients with fresh or dried buds psychoactive hemp and hashish oil, but also will become the only legal manufacturer of seeds or plants psychoactive hemp for persons who have received permission to use and wish to grow cannabis on their own, or their representatives, which patients will consider necessary to grant such right.
Does the new Regulation impact on recreational cannabis market?
No. Access to the use of psychoactive cannabis used for medical purposes is allowed only in cases stipulated by the relevant legal acts. Points of Sale recreational cannabis, popularly called "preventive" or "compassion clubs" do not have authorization for therapeutic cannabis sales. These representatives of the market selling mostly untested, substandard products. Their activities are not currently fully regulated by the rule of law and, therefore, potentially dangerous, as it has for the most part illegal sources of supply. The only legal way in Canada produce psychoactive cannabis for medical purposes, it is to buy raw materials in 34 certain state manufacturers, authorized by Health Canada.
It examines whether Health Canada are other ways to enable the use of psychoactive cannabis as a therapeutic agent?
Shall enter into force on the new Statute came as a result of the decision of the Supreme Court of Canada. The basic postulate of the above legal act is the creation of mechanisms to regulate the use of psychoactive cannabis for medical purposes. Health Canada undertakes to consider other possible models of patients' access to psychoactive cannabis, including through the use of licensed pharmacies.
Comment of the Association "Ukrainian industrial hemp"
Experience ensure the rule of law and improvement of the existing mechanisms to provide patients the possibility of the use of psychoactive cannabis for medical purposes is extremely interesting Ukrainian growers in consideration of changes in the profile law of Ukraine, which will give opportunity to develop the medical use of cannabis in the direction of our country.
Information taken from the site http://tku.org.ua